Feedback / Questions
fluorocyclopentenylcytosine (RX-3117) - Rexahn
https://investors.rexahn.com/press-releases/detail/293/rexahn-presents-updated-interim-data-from-phase-2a-trial-of
Feb 19, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next